FDA approves new blood test to detect colon cancer

Category: Health

The FDA approved Guardant Health's blood test Shield for colon cancer screening, which is expected to increase accessibility and insurance coverage. While effective in detecting later-stage cancers, it has limitations in identifying precancerous growths compared to traditional methods like colonoscopies. The test is approved for individuals 45 and older at average risk, aiming to improve screening rates and reduce mortality from colorectal cancer.

Keywords: FDA, colon cancer, blood test

Source: Popular Science

Update At: 7/30/2024

Related Sources